Legend Biotech (LEGN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Legend Biotech is undergoing a significant financial restructuring as Genscript Biotech has decided to deconsolidate the company’s financial statements. This move follows Genscript’s loss of control over voting power at Legend Biotech’s 2024 Annual General Meeting. Investors in the biotech sector may find this development noteworthy as it could impact the company’s financial reporting and market perception.
For further insights into LEGN stock, check out TipRanks’ Stock Analysis page.